Luris Higuera
Luris Higuera is the president of the Advocacy Commission of the Panamanian Rheumatoid Arthritis Foundation (Funarp), where she has been vocal about the challenges faced by patients with rheumatoid arthritis, particularly regarding the ineffectiveness of the biosimilar drug Rixathon and its impact on patient health and treatment costs.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Panama | 1 | 7.00 | 0.09% | +0% | 4,314,768 | 4,063 | $76,000 | 72$ |
| Totals | 1 | 4,314,768 | 4,063 | $76,000 | 72$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Panama:
Luris Higuera is the president of the Advocacy Commission of Funarp, an organization that groups patients with rheumatoid arthritis and other autoimmune diseases.
7